BUCHEN DAVID A
Insider CIK 1241751 · ACT See Remarks · AMRX SVP, Chief Legal Officer · WPI Exec VP,General Counsel & Sec.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2020-01-03 | 2020-01-06 | 27,614 | — | $0 | 82,843 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2020-01-03 | 2020-01-06 | 8,188 | $4.72 | $38.6K | 20,426 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2020-01-03 | 2020-01-06 | 27,614 | — | $0 | 28,614 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-01-03 | 2019-01-07 | 227,273 | — | $0 | 227,273 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-01-03 | 2019-01-07 | 110,457 | — | $0 | 110,457 | SEC↗ |
| ACT Actavis plc | A Award | 2015-03-05 | 2015-03-09 | 3,996 | — | $0 | 74,498 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-03-05 | 2015-03-09 | 448 | $295.70 | $132.5K | 74,050 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-03-05 | 2015-03-09 | 269 | $295.70 | $79.5K | 70,502 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 24,210 | — | $0 | 24,210 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 22,032 | — | $0 | 22,032 | SEC↗ |
| ACT Actavis plc | A Award | 2014-07-01 | 2014-07-03 | 7,845 | — | $0 | 70,771 | SEC↗ |
| ACT Actavis plc | A Award | 2014-05-09 | 2014-05-13 | 2,960 | $197.05 | $583.3K | 62,926 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-11-11 | 2013-11-13 | 30,000 | $159.30 | $4.78M | 59,966 | SEC↗ |
| ACT Actavis, Inc. | D To issuer | 2013-10-01 | 2013-10-02 | 89,966 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2013-10-01 | 2013-10-03 | 89,966 | — | $0 | 89,966 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-09-30 | 2013-10-02 | 45,848 | $144.00 | $6.60M | 89,966 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-09-30 | 2013-10-02 | 38,441 | — | $0 | 135,814 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-08-29 | 2013-09-03 | 5,000 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-08-29 | 2013-09-03 | 5,000 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-08-29 | 2013-09-03 | 5,000 | $35.11 | $175.6K | 102,373 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-08-29 | 2013-09-03 | 5,000 | $25.64 | $128.2K | 107,373 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-29 | 2013-09-03 | 10,000 | $135.56 | $1.36M | 97,373 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-08-12 | 2013-08-13 | 16,800 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-08-12 | 2013-08-13 | 16,800 | $26.14 | $439.2K | 114,373 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-12 | 2013-08-13 | 16,800 | $133.01 | $2.23M | 97,373 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-08-09 | 2013-08-13 | 200 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-09 | 2013-08-13 | 200 | $135.00 | $27.0K | 114,173 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-08-09 | 2013-08-13 | 200 | $26.14 | $5.2K | 97,573 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-03-15 | 2013-03-18 | 933 | $91.59 | $85.5K | 97,373 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-03-12 | 2013-03-13 | 1,600 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-03-12 | 2013-03-13 | 6,400 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-03-12 | 2013-03-13 | 1,600 | $38.92 | $62.3K | 99,906 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-03-12 | 2013-03-13 | 6,400 | $38.92 | $249.1K | 106,306 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-03-12 | 2013-03-13 | 8,000 | $89.00 | $712.0K | 98,306 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 6,716 | — | $0 | 98,306 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 7,960 | — | $0 | 91,590 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-03-05 | 2013-03-07 | 3,896 | $86.46 | $336.8K | 83,630 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-03-02 | 2013-03-05 | 5,030 | $85.54 | $430.3K | 87,526 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-10-31 | 2012-11-02 | 5,817 | — | $0 | 92,556 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise deriv | 2012-08-24 | 2012-08-24 | 24,294 | — | $0 | 0 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise deriv | 2012-08-24 | 2012-08-24 | 706 | — | $0 | 0 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise | 2012-08-24 | 2012-08-24 | 706 | $29.43 | $20.8K | 111,033 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | S Sale | 2012-08-24 | 2012-08-24 | 24,294 | $81.56 | $1.98M | 86,739 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise | 2012-08-24 | 2012-08-24 | 24,294 | $29.43 | $715.0K | 110,327 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise deriv | 2012-05-25 | 2012-05-30 | 11,101 | — | $0 | 0 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise deriv | 2012-05-25 | 2012-05-30 | 3,899 | — | $0 | 0 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | F Tax w/h | 2012-05-25 | 2012-05-30 | 6,366 | $72.67 | $462.6K | 86,033 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise | 2012-05-25 | 2012-05-30 | 3,899 | $26.40 | $102.9K | 92,399 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise | 2012-05-25 | 2012-05-30 | 11,101 | $26.40 | $293.1K | 88,500 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | F Tax w/h | 2012-03-14 | 2012-03-16 | 2,473 | $59.21 | $146.4K | 77,399 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-12 | 7,698 | — | $0 | 79,872 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-12 | 8,356 | — | $0 | 72,174 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | F Tax w/h | 2012-02-24 | 2012-02-28 | 2,754 | $58.17 | $160.2K | 63,818 | SEC↗ |